hunan xianshi pharmaceutical co , ltd
Hunan Xianshi Pharmaceutical Co., Ltd. was established on May 20, 2021, with a registered capital of 60 million yuan. It is a comprehensive pharmaceutical company focusing on the promotion, research and development, and production of high-quality pharmaceutical products. The company adheres to a development strategy based on research and development and oriented by industrial demand, and is committed to becoming a new force in promoting the development of China's pharmaceutical industry.
Hunan Xianshi Pharmaceutical Co., Ltd. was established on May 20, 2021, with a registered capital of 60 million yuan. It is a comprehensive pharmaceutical company focusing on the promotion, research and development, and production of high-quality pharmaceutical products. The company adheres to a development strategy based on research and development and oriented by industrial demand, and is committed to becoming a new force in promoting the development of China's pharmaceutical industry.
- Type
- Manufacturer
- Location
- Changsha, China
- Website
- https://www.hnxspharma.com
- Categories
- Pharmaceutical Manufacturing, Chemicals & Plastics
Listed in a source registry
Verified facts
- corporate-mail-on-domain (green), checked 2026-08-08 Mail server of the company domain
- domain-registered (green), checked 2026-08-08 Domain registry record
- debarment-clear (green), checked 2026-08-08 OpenSanctions
- lei-lapsed (amber), checked 2026-08-08 GLEIF
- sanctions-clear (green), checked 2026-08-08 OpenSanctions
Import rules for these goods
- Chemical substances imported into the EU above 1 tonne/year must be REACH-registered. ECHA (REACH)
- Medicines imported into the EU must come from a site holding an EU GMP certificate, and the importer needs a manufacturing/import authorisation. European Medicines Agency (GMP)